MARKET

GRAL

GRAL

Grail Inc
NASDAQ
75.89
+0.36
+0.48%
After Hours: 75.89 0 0.00% 19:30 09/15 EDT
OPEN
75.44
PREV CLOSE
75.53
HIGH
77.93
LOW
74.27
VOLUME
1.51M
TURNOVER
--
52 WEEK HIGH
118.84
52 WEEK LOW
36.98
MARKET CAP
3.39B
P/E (TTM)
-7.7869
1D
5D
1M
3M
1Y
5Y
1D
FDA Advisory Panel Poses Pivotal Binary Event for GRAIL’s Galleri, Keeping Risk‑Reward Balanced and Rating at Hold
TipRanks · 12h ago
Weekly Report: what happened at GRAL last week (0907-0911)?
Weekly Report · 1d ago
UBS Initiates a Buy Rating on GRAIL Inc (GRAL)
TipRanks · 1d ago
Grail Price Target Announced at $105.00/Share by UBS
Dow Jones · 6d ago
UBS Initiates Coverage On GRAIL with Buy Rating, Announces Price Target of $105
Benzinga · 6d ago
Grail initiated with a Buy at UBS
TipRanks · 6d ago
Grail CFO Aaron Freidin Sells 7,900 Shares for $672,000
The Motley Fool · 6d ago
Weekly Report: what happened at GRAL last week (0831-0904)?
Weekly Report · 09/07 09:50
More
About GRAL
Grail, Inc. is a healthcare company focused on saving lives and shifting the paradigm in early cancer detection. The Company is focused on alleviating the global burden of cancer by using sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its multi-cancer early detection test, the Galleri test, is a commercially available screening test for early detection of multiple types of cancer. The Galleri test can be used to screen for cancer before a person becomes symptomatic, when cancer may be more easily treated and potentially curable. The Galleri test can indicate the origin of the cancer.

Webull offers Grail Inc stock information, including NASDAQ: GRAL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRAL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRAL stock methods without spending real money on the virtual paper trading platform.